Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
4D Molecular Therapeutics, Inc.
4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
July 18, 2026
4DMT Announces New Employment Inducement Grants
July 17, 2026
4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists
June 30, 2026
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
June 29, 2026
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
June 29, 2026
4DMT Announces New Employment Inducement Grants
June 12, 2026
4DMT to Participate in Upcoming Investor Conferences
May 31, 2026
4DMT Announces New Employment Inducement Grants
May 30, 2026
4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
May 29, 2026
4DMT to Participate in Upcoming Investor Conferences
May 28, 2026
1
2
Next Page
→